Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
BMJ Open
|
March 6, 2020
How valid are projections of the future prevalence of diabetes? Rapid reviews of prevalence-based and Markov chain models and comparisons of different models' projections for England
Gwyn Bevan, Chiara De Poli, Mi Jun Keng, et al.
Pharmacoeconomics
|
November 10, 2023
Estimating Costs Associated with Disease Model States Using Generalized Linear Models: A Tutorial
Junwen Zhou, Claire Williams, Mi Jun Keng, et al.
Diabetes, Obesity & Metabolism
|
December 6, 2021
Decrements in health-related quality of life associated with adverse events in people with diabetes
Mi Jun Keng, Jose Leal, Louise Bowman, et al.
Diabetes, Obesity & Metabolism
|
July 3, 2019
Impact of achieving primary care targets in type 2 diabetes on health outcomes and healthcare costs
Mi Jun Keng, Apostolos Tsiachristas, Jose Leal, et al.
Diabetes, Obesity & Metabolism
|
June 9, 2022
Hospital costs associated with adverse events in people with diabetes in the UK
Mi Jun Keng, Jose Leal, Louise Bowman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 1, 2022
Performance of the UK Prospective Diabetes Study Outcomes Model 2 in a Contemporary UK Type 2 Diabetes Trial Cohort
Mi Jun Keng, Jose Leal, Marion Mafham, et al.
Journal of Comparative Effectiveness Research
|
August 12, 2025
Identification of treatment effect modifiers and prognostic factors in newly diagnosed and relapsed or refractory multiple myeloma
Jianming He, Karen Chiang, Xiwu Lin, et al.
Journal of the American Heart Association
|
September 26, 2023
Impact of New Cardiovascular Events on Quality of Life and Hospital Costs in People With Cardiovascular Disease in the United Kingdom and United States
Juliana Nga Man Lui, Claire Williams, Mi Jun Keng, et al.
Advances in Therapy
|
March 12, 2026
Indirect Comparison of Nipocalimab Versus Efgartigimod and Rozanolixizumab in the Treatment of Generalized Myasthenia Gravis
Saiju Jacob, Mahmoud Hashim, Brian Hutton, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
July 10, 2024
Examining the Impact of Structural Uncertainty Across 10 Type 2 Diabetes Models: Results From the 2022 Mount Hood Challenge
James Altunkaya, Xinyu Li, Amanda Adler, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
BMJ Open
|
March 6, 2020
How valid are projections of the future prevalence of diabetes? Rapid reviews of prevalence-based and Markov chain models and comparisons of different models' projections for England
Gwyn Bevan, Chiara De Poli, Mi Jun Keng, et al.
Pharmacoeconomics
|
November 10, 2023
Estimating Costs Associated with Disease Model States Using Generalized Linear Models: A Tutorial
Junwen Zhou, Claire Williams, Mi Jun Keng, et al.
Diabetes, Obesity & Metabolism
|
December 6, 2021
Decrements in health-related quality of life associated with adverse events in people with diabetes
Mi Jun Keng, Jose Leal, Louise Bowman, et al.
Diabetes, Obesity & Metabolism
|
July 3, 2019
Impact of achieving primary care targets in type 2 diabetes on health outcomes and healthcare costs
Mi Jun Keng, Apostolos Tsiachristas, Jose Leal, et al.
Diabetes, Obesity & Metabolism
|
June 9, 2022
Hospital costs associated with adverse events in people with diabetes in the UK
Mi Jun Keng, Jose Leal, Louise Bowman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 1, 2022
Performance of the UK Prospective Diabetes Study Outcomes Model 2 in a Contemporary UK Type 2 Diabetes Trial Cohort
Mi Jun Keng, Jose Leal, Marion Mafham, et al.
Journal of Comparative Effectiveness Research
|
August 12, 2025
Identification of treatment effect modifiers and prognostic factors in newly diagnosed and relapsed or refractory multiple myeloma
Jianming He, Karen Chiang, Xiwu Lin, et al.
Journal of the American Heart Association
|
September 26, 2023
Impact of New Cardiovascular Events on Quality of Life and Hospital Costs in People With Cardiovascular Disease in the United Kingdom and United States
Juliana Nga Man Lui, Claire Williams, Mi Jun Keng, et al.
Advances in Therapy
|
March 12, 2026
Indirect Comparison of Nipocalimab Versus Efgartigimod and Rozanolixizumab in the Treatment of Generalized Myasthenia Gravis
Saiju Jacob, Mahmoud Hashim, Brian Hutton, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
July 10, 2024
Examining the Impact of Structural Uncertainty Across 10 Type 2 Diabetes Models: Results From the 2022 Mount Hood Challenge
James Altunkaya, Xinyu Li, Amanda Adler, et al.
Page
of 1